Fast Track Appraisal for New Treatments with ICERs under £10k and Higher Thresholds for HST Proposed by NICE and NHSE
NICE and NHS England have launched a consultation about the process for authorising new treatments and the introduction of an affordability test.
Summary of the proposals
- Introduce a ‘fast track’ NICE technology appraisal process for promising new technologies with ICERs < £10k per QALY, to get these treatments to patients more quickly
- Operate a ‘budget impact threshold’ of £20 million, set by NHS England, to signal the need for a dialogue with companies to agree special arrangements to better manage the introduction of new technologies recommended by NICE. This would apply to a small number of technologies that, once determined as cost effective by NICE, would have a significant impact on the NHS budget
- Vary the timescale for the funding requirement when the budget impact threshold is reached or exceeded, and there is therefore a compelling case that the introduction of the new technology would risk disruption to the funding of other services
- Automatically fund, from routine commissioning budgets, treatments for very rare conditions (highly specialised technologies, HST) up to £100,000 per QALY (5x the lower end of NICE’s standard threshold range), and provide the opportunity for treatments above this range to be considered through NHS England’s process for prioritising other highly specialised technologies